Abstract
Objective To observe the application of staged goal-directed fluid therapy (GDFT) in anesthesia for renal transplantation. Methods A total of thirty patients scheduled for allogeneic renal transplantation were randomly divided into two groups, groups A and B (n=15). Group A was given staged goal-directed fluid therapy [stroke volume variation (SVV) ≤13 was set in accordance with the surgical progress before refusion in the new kidney and ≤10 after refusion, which is the basis of fluid management]. Meanwhile, group B was given goal-directed fluid therapy(where SVV≤13 was set). Then, the mean artery pressure (MAP), heart rate and stroke volume (SV) were recorded before the surgery after anesthesia, before refusion in the new kidney and 15 min after refusion. Furthermore, the content of blood lactic acid before and after surgery, the blood creatinine (Cr) content and urine volume before the surgery and 1, 2 d and 3 d after surgery were also recorded. Results There was no differences in MAP, heart rate and SV between the two groups before surgery (P>0.05). Group A presented remarkably increases in MAP and SV before refusion and 15 min after refusion, compared with group B (P 0.05). Conclusions Application of staged goal-directed fluid therapy in anesthesia for renal transplantation is favorable for recovery of renal functions after renal transplantation, if adequate blood perfusion can be ensured for the kidney. Key words: Staged goal-directed fluid therapy; Stroke volume variation; Renal transplant
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call